Synthetic Biologics, Intrexon begin mAb therapy development for whooping cough
To manage the rising number of pertussis cases, Synthetic Biologics intends to decrease the mortality rate in infants as well as to decrease the chronic cough in adults
SK bioscience is set to lead the Gates Foundation-fundedResearch Optimization & Trial Outcome Recommender (ROTOR) project, an AI-based platform aimed at reducing uncertainty in vaccine-development decisions.
Under the agreement, Arrowhead will receive research funding and could be eligible for development, regulatory and commercialization milestone payments of approximately $32.8m for each development candidate, an additional